169
Anika Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
170
FY23:
163
FY24:
114
FY25:
103
(positive)
Change from FY21 to FY25
millions USD
FY21:
179
FY22:
180
FY23:
107
FY24:
89.1
FY25:
86.9
Total assets
Change from FY21 to FY25
millions USD
FY21:
348
FY22:
349
FY23:
271
FY24:
203
FY25:
190
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
29.8
FY22:
27.9
FY23:
31.1
FY24:
23.3
FY25:
21.9
(negative)
Change from FY21 to FY25
millions USD
FY21:
30.7
FY22:
35.7
FY23:
27.3
FY24:
25.4
FY25:
24.9
(positive)
Change from FY21 to FY25
millions USD
FY21:
287
FY22:
286
FY23:
212
FY24:
154
FY25:
143
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
348
FY22:
349
FY23:
271
FY24:
203
FY25:
190
All amounts in millions USD